Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

BACKGROUND: Artesunate plus sulphadoxine-pyrimethamine (AS+SP) is now first-line treatment for Plasmodium falciparum infection in several south Asian countries, including Afghanistan. Molecular studies provide a sensitive means to investigate the current state of drug susceptibility to the SP compon...

Detaylı Bibliyografya
Asıl Yazarlar:	Awab, G, Pukrittayakamee, S, Jamornthanyawat, N, Yamin, F, Dondorp, A, Day, N, White, N, Woodrow, C, Imwong, M
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BioMed Central 2013

Benzer Materyaller

A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan
Yazar:: Jamornthanyawat, N, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
Yazar:: Rakmark, K, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
Yazar:: Kasama Rakmark, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
Yazar:: Karema, C, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
Yazar:: Awab, GR, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
Yazar:: Natsuda Jamornthanyawat, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
Yazar:: Sugaram, R, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
Yazar:: Leartsakulpanich, U, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
Yazar:: Rungniran Sugaram, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
Yazar:: Awab, G, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors.
Yazar:: Preechapornkul, P, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Escalating <it>Plasmodium falciparum </it>antifolate drug resistance mutations in Macha, rural Zambia
Yazar:: Rouse Petrica, ve diğerleri
Baskı/Yayın Bilgisi: (2008-05-01)

Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.
Yazar:: Preechapornkul, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Molecular markers of antifolate resistance in <it>Plasmodium falciparum </it>isolates from Luanda, Angola
Yazar:: Almeida de Oliveira Natália K, ve diğerleri
Baskı/Yayın Bilgisi: (2011-08-01)

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
Yazar:: Awab, GR, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
Yazar:: Srisutham, S, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.
Yazar:: Suttipat Srisutham, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
Yazar:: Win, AA, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
Yazar:: Mayke J A M Oesterholt, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

Chloroquine-primaquine versus chloroquine alone to treat Vivax malaria in Afghanistan: An open randomized superiority trial.
Yazar:: Awab, G, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
Yazar:: Woodrow Charles J, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Tracing the origins and signatures of selection of antifolate resistance in island populations of <it>Plasmodium falciparum</it>
Yazar:: Pinto João, ve diğerleri
Baskı/Yayın Bilgisi: (2010-06-01)

Independent Origin of Plasmodium falciparum Antifolate Super-Resistance, Uganda, Tanzania, and Ethiopia
Yazar:: Michael Alifrangis, ve diğerleri
Baskı/Yayın Bilgisi: (2014-08-01)

Laboratory detection of artemisinin-resistant Plasmodium falciparum.
Yazar:: Chotivanich, K, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Yazar:: Dennis W Juma, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension.
Yazar:: Nair, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Prevalence of chloroquine and antifolate drug resistance alleles in Plasmodium falciparum clinical isolates from three areas in Ghana [version 2; peer review: 2 approved]
Yazar:: James Abugri, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Limited polymorphism of the Kelch propeller domain in Plasmodium malariae and P. ovale isolates from Thailand.
Yazar:: Nakeesathit, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum.
Yazar:: Imwong, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.
Yazar:: Mukherjee, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Type 2 antifolates in the chemotherapy of falciparum malaria
Yazar:: Delfino Reinaldo T., ve diğerleri
Baskı/Yayın Bilgisi: (2002-01-01)

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
Yazar:: Ghulam R Awab, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Protein-based signatures of functional evolution in Plasmodium falciparum
Yazar:: Gardner, K, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Protein-based signatures of functional evolution in Plasmodium falciparum.
Yazar:: Gardner, K, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Strong protective effect of Mediterranean type glucose-6-phosphate dehydrogenase deficiency against vivax malaria
Yazar:: Awab, GR, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates.
Yazar:: Karthikeyan Ganesan, ve diğerleri
Baskı/Yayın Bilgisi: (2008-11-01)

Molecular surveillance of the antifolate-resistant mutation I164L in imported african isolates of <it>Plasmodium falciparum </it>in Europe: sentinel data from TropNetEurop
Yazar:: McWhinney Paul, ve diğerleri
Baskı/Yayın Bilgisi: (2003-06-01)

Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar.
Yazar:: Imwong, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009
Yazar:: Alegana, V, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
Yazar:: Mayxay, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)